Zusammenfassung
Aus pluripotenten Stammzellen gewonnene Kardiomyozyten (PSC-CMs) haben ein großes Potenzial als Quelle für Kardiomyozyten, um abgestorbene Zellen bei Herzerkrankungen zu ersetzen (regenerative Medizin), die Pathophysiologie vererbter Herzerkrankungen wie Kardiomyopathie nachzuvollziehen (Krankheitsmodellierung) und die Toxizität neu entwickelter Arzneimittel in vitro zu testen (Arzneimittelforschung). Dank der Fortschritte, die in den letzten zwei Jahrzehnten bei der Gewinnung von PSC-CMs erzielt wurden, können hochgradig gereinigte PSC-CMs mit hoher Ausbeute zur Behandlung von Patienten hergestellt werden. Aufgrund ihrer Unreife, die einem fötalen Stadium ähnelt, ist der Nutzen von PSC-CMs für die Krankheitsmodellierung und die Entdeckung von Medikamenten jedoch noch begrenzt. Daher gewinnt die Reifung von Kardiomyozyten zunehmend an Bedeutung. In diesem Kapitel fassen wir die wichtigsten Merkmale zusammen, die unreife und reife Kardiomyozyten definieren, sowie den Prozess, wie Kardiomyozyten im Herzen reifen. Angesichts der Erkenntnis, dass PSC-CMs nach der Transplantation in Herzen reifer sind, müssen geeignete Umgebungsbedingungen entscheidend für die Reifung sein. Daher werden mögliche Einflussfaktoren wie Zeit (verlängerte Kultur), Kulturumgebungen (z. B. extrazelluläre Matrizen, postnatale Hormone, Veränderungen der Stoffwechselsubstrate und Substratsteifigkeit), interzelluläre Kommunikation (z. B. physikalische Stimulationen und die Auswirkungen benachbarter Nicht-Kardiomyozyten), In-vivo-Reifung und dreidimensionale Kultursysteme untersucht. Am Ende des Kapitels geben wir auch einen Ausblick auf die Verwendung reifer PSC-CMs in der Krankheitsmodellierung, der Arzneimittelforschung und der regenerativen Medizin.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AP:
-
Aktionspotenzial
- ARVD/C:
-
Arrhythmogene rechtsventrikuläre Dysplasie/Kardiomyopathie
- BMP:
-
Morphogenetisches Knochenprotein
- Cx43:
-
Connexin 43
- CDK:
-
Cyclin-abhängige Kinase
- DCM:
-
Dilatative Kardiomyopathie
- ES-Zellen:
-
Embryonale Stammzellen
- ECMs:
-
Extrazelluläre Matrices
- FAO:
-
β-Oxidation von Fettsäuren
- hCMPs:
-
Menschliche Herzmuskel-Patches
- hERG:
-
Menschliches Ether-a-go-go-verwandtes Gen
- HCN4:
-
Hyperpolarisations-aktivierter durch zyklische Nukleotide gesteuerter Kanal 4
- iPS-Zellen:
-
Induzierte pluripotente Stammzellen
- LTCCs:
-
Kalziumkanäle vom L-Typ
- MI:
-
Myokardinfarkt
- MHC:
-
Schwere Myosinkette
- NRVMs:
-
Neonatale ventrikuläre Myozyten der Ratte
- PKP2:
-
Plakophilin-2
- PSCs:
-
Pluripotente Stammzellen
- PSC-CMs:
-
Aus pluripotenten Stammzellen gewonnene Kardiomyozyten
- RBM20:
-
RNA-Bindungsmotiv-Protein 20
- RYRs:
-
Ryanodin-Rezeptoren
- SR:
-
Sarkoplasmatisches Retikulum
- SERCA2a:
-
Kalzium-ATPase 2a des sarkoplasmatischen/endoplasmatischen Retikulums
- NCX:
-
Natrium-Calcium-Austauscher
- T-Tubuli:
-
Transversaltubuli
Literatur
Abu-Issa R, Kirby ML (2007) Heart field: from mesoderm to heart tube. Annu Rev Cell Dev Biol 23:45–68
Bajaj P, Tang X, Saif TA, Bashir R (2010) Stiffness of the substrate influences the phenotype of embryonic chicken cardiac myocytes. J Biomed Mater Res A 95(4):1261–1269
Bedada FB, Chan SS-K, Metzger SK, Zhang L, Zhang J, Garry DJ et al (2014) Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes. Stem Cell Rep 3(4):594–605
Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K, Bernard S et al (2015) Dynamics of cell generation and turnover in the human heart. Cell 161(7):1566–1575
Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415(6868):198–205
Bird SD, Doevendans PA, van Rooijen MA, Brutel de la Riviere A, Hassink RJ, Passier R et al (2003) The human adult cardiomyocyte phenotype. Cardiovasc Res 58(2):423–434
Braam SR, Passier R, Mummery CL (2009) Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol Sci 30(10):536–545
Brodsky VY, Sarkisov DS, Arefyeva AM, Panova NW, Gvasava IG (1994) Polyploidy in cardiac myocytes of normal and hypertrophic human hearts; range of values. Virchows Arch 424(4):429–435
Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD et al (2014) Chemically defined generation of human cardiomyocytes. Nat Methods 11(8):855–860
Carmeliet E (2019) Pacemaking in cardiac tissue. From IK2 to a coupled-clock system. Physiol Rep 7(1):e13862
Carvajal-Vergara X, Sevilla A, D’Souza SL, Ang Y-S, Schaniel C, Lee D-F et al (2010) Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465(7299):808–812
Chanthra N, Abe T, Miyamoto M, Sekiguchi K, Kwon C, Hanazono Y et al (2020) A novel fluorescent reporter system identifies Laminin-511/521 as potent regulators of cardiomyocyte maturation. Sci Rep 10(1):4249
Chen VC, Ye J, Shukla P, Hua G, Chen D, Lin Z et al (2015) Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. Stem Cell Res 15(2):365–375
Cho G-S, Lee DI, Tampakakis E, Murphy S, Andersen P, Uosaki H et al (2017) Neonatal transplantation confers maturation of PSC-derived cardiomyocytes conducive to modeling cardiomyopathy. Cell Rep 18(2):571–582
Correia C, Koshkin A, Duarte P, Hu D, Teixeira A, Domian I et al (2017) Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Sci Rep 7(1):8590
Dai D-F, Danoviz ME, Wiczer B, Laflamme MA, Tian R (2017) Mitochondrial maturation in human pluripotent stem cell derived cardiomyocytes. Stem Cells Int 2017:5153625
Denning C, Borgdorff V, Crutchley J, Firth KSA, George V, Kalra S et al (2016) Cardiomyocytes from human pluripotent stem cells: from laboratory curiosity to industrial biomedical platform. Biochim Biophys Acta 1863(7 Pt B):1728–1748
Dubois NC, Craft AM, Sharma P, Elliott DA, Stanley EG, Elefanty AG et al (2011) SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol 29(11):1011–1018
Escobar AL, Ribeiro-Costa R, Villalba-Galea C, Zoghbi ME, Pérez CG, Mejía-Alvarez R (2004) Developmental changes of intracellular Ca2+ transients in beating rat hearts. Am J Physiol Heart Circ Physiol 286(3):H971–H978
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154–156
Feric NT, Radisic M (2016) Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv Drug Deliv Rev 96:110–134
Feyen DAM, McKeithan WL, Bruyneel AAN, Spiering S, Hörmann L, Ulmer B et al (2020) Metabolic maturation media improve physiological function of human iPSC-derived cardiomyocytes. Cell Rep 32(3):107925
Frawley LE, Orr-Weaver TL (2015) Polyploidy. Curr Biol CB 25(9):R353–R358
Friedman CE, Nguyen Q, Lukowski SW, Helfer A, Chiu HS, Miklas J et al (2018) Single-cell transcriptomic analysis of cardiac differentiation from human PSCs reveals HOPX-dependent cardiomyocyte maturation. Cell Stem Cell 23(4):586–598.e8
Funakoshi S, Miki K, Takaki T, Okubo C, Hatani T, Chonabayashi K et al (2016) Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep 6:19111
Galdos FX, Guo Y, Paige SL, VanDusen NJ, Wu SM, Pu WT (2017) Cardiac regeneration: lessons from development. Circ Res 120(6):941–959
Gao L, Gregorich ZR, Zhu W, Mattapally S, Oduk Y, Lou X et al (2018) Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation 137(16):1712–1730
Gerdes AM, Kellerman SE, Moore JA, Muffly KE, Clark LC, Reaves PY et al (1992) Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation 86(2):426–430
Germanguz I, Sedan O, Zeevi-Levin N, Shtrichman R, Barak E, Ziskind A et al (2011) Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J Cell Mol Med 15(1):38–51
González-Rosa JM, Sharpe M, Field D, Soonpaa MH, Field LJ, Burns CE et al (2018) Myocardial Polyploidization creates a barrier to heart regeneration in zebrafish. Dev Cell 44(4):433–446.e7
Goversen B, van der Heyden MAG, van Veen TAB, de Boer TP (2018) The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: special focus on IK1. Pharmacol Ther 183:127–136
Guo L, Abrams RMC, Babiarz JE, Cohen JD, Kameoka S, Sanders MJ et al (2011) Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci Off J Soc Toxicol 123(1):281–289
Guo Y, Pu WT (2020) Cardiomyocyte maturation: new phase in development. Circ Res 126(8):1086–1106
Herron TJ, Rocha AMD, Campbell KF, Ponce-Balbuena D, Willis BC, Guerrero-Serna G et al (2016) Extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function. Circ Arrhythm Electrophysiol 9(4):e003638
Hinson JT, Chopra A, Nafissi N, Polacheck WJ, Benson CC, Swist S et al (2015) HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349(6251):982–986
Hirose K, Payumo AY, Cutie S, Hoang A, Zhang H, Guyot R et al (2019) Evidence for hormonal control of heart regenerative capacity during endothermy acquisition. Science 364(6436):184–188
Hoekstra M, Mummery CL, Wilde AAM, Bezzina CR, Verkerk AO (2012) Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias. Front Physiol 3:346
Horikoshi Y, Yan Y, Terashvili M, Wells C, Horikoshi H, Fujita S et al (2019) Fatty acid-treated induced pluripotent stem cell-derived human cardiomyocytes exhibit adult cardiomyocyte-like energy metabolism phenotypes. Cell 8(9):1095
Huang J, Hove-Madsen L, Tibbits GF (2008) Ontogeny of Ca2+−induced Ca2+ release in rabbit ventricular myocytes. Am J Physiol Cell Physiol 294(2):C516–C525
Iorga B, Schwanke K, Weber N, Wendland M, Greten S, Piep B et al (2017) Differences in contractile function of myofibrils within human embryonic stem cell-derived cardiomyocytes vs. adult ventricular myofibrils are related to distinct sarcomeric protein isoforms. Front Physiol 8:1111
Itzhaki I, Rapoport S, Huber I, Mizrahi I, Zwi-Dantsis L, Arbel G et al (2011) Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 6(4):e18037
Jacot JG, McCulloch AD, Omens JH (2008) Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophys J 95(7):3479–3487
Jacot JG, Martin JC, Hunt DL (2010) Mechanobiology of cardiomyocyte development. J Biomech 43(1):93–98
Janowski E, Cleemann L, Sasse P, Morad M (2006) Diversity of Ca2+ signaling in develo** cardiac cells. Ann N Y Acad Sci 1080:154–164
Jiang Y, Park P, Hong S-M, Ban K (2018) Maturation of cardiomyocytes derived from human pluripotent stem cells: current strategies and limitations. Mol Cells 41(7):613–621
Jonsson MKB, Vos MA, Mirams GR, Duker G, Sartipy P, de Boer TP et al (2012) Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG. J Mol Cell Cardiol 52(5):998–1008
Kadota S, Shiba Y (2019) Pluripotent stem cell-derived cardiomyocyte transplantation for heart Disease treatment. Curr Cardiol Rep 21(8):73
Kadota S, Minami I, Morone N, Heuser JE, Agladze K, Nakatsuji N (2013) Development of a reentrant arrhythmia model in human pluripotent stem cell-derived cardiac cell sheets. Eur Heart J 34(15):1147–1156
Kadota S, Pabon L, Reinecke H, Murry CE (2017) In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts. Stem Cell Rep 8(2):278–289
Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J et al (2013) Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J 77(5):1307–1314
Kane C, Couch L, Terracciano CMN (2015) Excitation-contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes. Front Cell Dev Biol 3:59
Karakikes I, Ameen M, Termglinchan V, Wu JC (2015) Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Circ Res 117(1):80–88
Karbassi E, Fenix A, Marchiano S, Muraoka N, Nakamura K, Yang X et al (2020) Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat Rev Cardiol 17(6):341–359
Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A et al (2011) Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8(2):228–240
Kawatou M, Masumoto H, Fukushima H, Morinaga G, Sakata R, Ashihara T et al (2017) Modelling torsade de pointes arrhythmias in vitro in 3D human iPS cell-engineered heart tissue. Nat Commun 8(1):1078
Kempf H, Kropp C, Olmer R, Martin U, Zweigerdt R (2015) Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nat Protoc 10(9):1345–1361
Kim C, Majdi M, **a P, Wei KA, Talantova M, Spiering S et al (2010) Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation. Stem Cells Dev 19(6):783–795
Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S et al (2013) Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 494(7435):105–110
Kosmidis G, Bellin M, Ribeiro MC, van Meer B, Ward-van Oostwaard D, Passier R et al (2015) Altered calcium handling and increased contraction force in human embryonic stem cell derived cardiomyocytes following short term dexamethasone exposure. Biochem Biophys Res Commun 467(4):998–1005
Krüger M, Sachse C, Zimmermann WH, Eschenhagen T, Klede S, Linke WA (2008) Thyroid hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/AKT pathway. Circ Res 102(4):439–447
Laflamme MA, Murry CE (2011) Heart regeneration. Nature 473(7347):326–335
Lan F, Lee AS, Liang P, Sanchez-Freire V, Nguyen PK, Wang L et al (2013) Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 12(1):101–113
Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM et al (2012) Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 109(27):E1848–E1857
Lian X, Bao X, Zilberter M, Westman M, Fisahn A, Hsiao C et al (2015) Chemically defined, albumin-free human cardiomyocyte generation. Nat Methods 12(7):595–596
Liu A, Tang M, ** J, Gao L, Zheng Y, Luo H et al (2010) Functional characterization of inward rectifier potassium ion channel in murine fetal ventricular cardiomyocytes. Cell Physiol Biochem 26(3):413–420
Liu H, Zhang C-H, Ammanamanchi N, Suresh S, Lewarchik C, Rao K et al (2019) Control of cytokinesis by β-adrenergic receptors indicates an approach for regulating cardiomyocyte endowment. Sci Transl Med 11(513):eaaw6419
Liu J, Fu JD, Siu CW, Li RA (2007) Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 25(12):3038–3044
Liu J, Lieu DK, Siu CW, Fu J-D, Tse H-F, Li RA (2009) Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression. Am J Physiol Cell Physiol 297(1):C152–C159
Liu W, Yasui K, Opthof T, Ishiki R, Lee J-K, Kamiya K et al (2002) Developmental changes of ca(2+) handling in mouse ventricular cells from early embryo to adulthood. Life Sci 71(11):1279–1292
Lompre AM, Schwartz K, d’Albis A, Lacombe G, Van Thiem N, Swynghedauw B (1979) Myosin isoenzyme redistribution in chronic heart overload. Nature 282(5734):105–107
Lopaschuk GD, Jaswal JS (2010) Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol 56(2):130–140
Lundy SD, Zhu W-Z, Regnier M, Laflamme MA (2013) Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 22(14):1991–2002
McCain ML, Parker KK (2011) Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function. Pflugers Arch 462(1):89–104
McCain ML, Agarwal A, Nesmith HW, Nesmith AP, Parker KK (2014) Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues. Biomaterials 35(21):5462–5471
Minami I, Yamada K, Otsuji TG, Yamamoto T, Shen Y, Otsuka S et al (2012) A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep 2(5):1448–1460
Miquerol L, Kelly RG (2013) Organogenesis of the vertebrate heart. Wiley Interdiscip Rev Dev Biol 2(1):17–29
Mohamed TMA, Ang Y-S, Radzinsky E, Zhou P, Huang Y, Elfenbein A et al (2018) Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 173(1):104–116.e12
Mollova M, Bersell K, Walsh S, Savla J, Das LT, Park S-Y et al (2013) Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci U S A 110(4):1446–1451
Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flügel L et al (2010) Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363(15):1397–1409
Nakamura K, Murry CE (2019) Function follows form – a review of cardiac cell therapy. Circ J 83(12):2399–2412
Nakano H, Minami I, Braas D, Pappoe H, Wu X, Sagadevan A et al (2017) Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis. Elife 6:e29330
Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, **ao Y, Zhang B et al (2013) Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 10(8):781–787
Olivetti G, Cigola E, Maestri R, Corradi D, Lagrasta C, Gambert SR et al (1996) Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol 28(7):1463–1477
Parikh SS, Blackwell DJ, Gomez-Hurtado N, Frisk M, Wang L, Kim K et al (2017) Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived cardiomyocytes. Circ Res 121(12):1323–1330
Patterson M, Barske L, Van Handel B, Rau CD, Gan P, Sharma A et al (2017) Frequency of mononuclear diploid cardiomyocytes underlies natural variation in heart regeneration. Nat Genet 49(9):1346–1353
Peters NS, Severs NJ, Rothery SM, Lincoln C, Yacoub MH, Green CR (1994) Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation 90(2):713–725
Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN et al (2011) Transient regenerative potential of the neonatal mouse heart. Science 331(6020):1078–1080
Porter GA, Hom J, Hoffman D, Quintanilla R, de Mesy BK, Sheu S-S (2011) Bioenergetics, mitochondria, and cardiac myocyte differentiation. Prog Pediatr Cardiol 31(2):75–81
Prakash YS, Cody MJ, Housmans PR, Hannon JD, Sieck GC (1999) Comparison of cross-bridge cycling kinetics in neonatal vs. adult rat ventricular muscle. J Muscle Res Cell Motil 20(7):717–723
Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R et al (2004) Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A 101(52):18129–18134
Reinecke H, Zhang M, Bartosek T, Murry CE (1999) Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100(2):193–202
Ruan J-L, Tulloch NL, Razumova MV, Saiget M, Muskheli V, Pabon L et al (2016) Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation 134(20):1557–1567
Sabry MA, Dhoot GK (1989) Identification and pattern of expression of a developmental isoform of troponin I in chicken and rat cardiac muscle. J Muscle Res Cell Motil 10(1):85–91
Saggerson D (2008) Malonyl-CoA, a key signaling molecule in mammalian cells. Annu Rev Nutr 28:253–272
Sartiani L, Bettiol E, Stillitano F, Mugelli A, Cerbai E, Jaconi ME (2007) Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 25(5):1136–1144
Sathaye A, Bursac N, Sheehy S, Tung L (2006) Electrical pacing counteracts intrinsic shortening of action potential duration of neonatal rat ventricular cells in culture. J Mol Cell Cardiol 41(4):633–641
Satin J, Itzhaki I, Rapoport S, Schroder EA, Izu L, Arbel G et al (2008) Calcium handling in human embryonic stem cell-derived cardiomyocytes. Stem Cells 26(8):1961–1972
Schaper J, Meiser E, Stämmler G (1985) Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts. Circ Res 56(3):377–391
Scuderi GJ, Butcher J (2017) Naturally engineered maturation of cardiomyocytes. Front Cell Dev Biol 5:50
Seppet EK, Kaambre T, Sikk P, Tiivel T, Vija H, Tonkonogi M et al (2001) Functional complexes of mitochondria with Ca, MgATPases of myofibrils and sarcoplasmic reticulum in muscle cells. Biochim Biophys Acta 1504(2–3):379–395
Shadrin IY, Allen BW, Qian Y, Jackman CP, Carlson AL, Juhas ME et al (2017) Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. Nat Commun 8(1):1825
Shiba Y, Fernandes S, Zhu W-Z, Filice D, Muskheli V, Kim J et al (2012) Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489(7415):322–325
Siedner S, Krüger M, Schroeter M, Metzler D, Roell W, Fleischmann BK et al (2003) Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol 548(Pt 2):493–505
Skelton RJP, Kamp TJ, Elliott DA, Ardehali R (2017) Biomarkers of human pluripotent stem cell-derived cardiac lineages. Trends Mol Med 23(7):651–668
Snir M, Kehat I, Gepstein A, Coleman R, Itskovitz-Eldor J, Livne E et al (2003) Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol 285(6):H2355–H2363
Soonpaa MH, Kim KK, Pajak L, Franklin M, Field LJ (1996) Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Phys 271(5 Pt 2):H2183–H2189
Spach MS, Heidlage JF, Dolber PC, Barr RC (2000) Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth. Circ Res 86(3):302–311
Spach MS, Heidlage JF, Barr RC, Dolber PC (2004) Cell size and communication: role in structural and electrical development and remodeling of the heart. Heart Rhythm 1(4):500–515
Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, Abilez OJ et al (2012) Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 4(130):130ra47
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872
Tam PPL, Loebel DAF (2007) Gene function in mouse embryogenesis: get set for gastrulation. Nat Rev Genet 8(5):368–381
Tanaka H, Shigenobu K (1989) Effect of ryanodine on neonatal and adult rat heart: developmental increase in sarcoplasmic reticulum function. J Mol Cell Cardiol 21(12):1305–1313
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, Matsuura T et al (2013) Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12(1):127–137
Tohyama S, Fujita J, Hishiki T, Matsuura T, Hattori F, Ohno R et al (2016) Glutamine oxidation is indispensable for survival of human pluripotent stem cells. Cell Metab 23(4):663–674
Uosaki H, Fukushima H, Takeuchi A, Matsuoka S, Nakatsuji N, Yamanaka S et al (2011) Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One 6(8):e23657
Uosaki H, Cahan P, Lee DI, Wang S, Miyamoto M, Fernandez L et al (2015) Transcriptional landscape of cardiomyocyte maturation. Cell Rep 13(8):1705–1716
VanWinkle WB, Snuggs MB, Buja LM (1996) Cardiogel: a biosynthetic extracellular matrix for cardiomyocyte culture. In Vitro Cell Dev Biol Anim 32(8):478–485
Veerman CC, Mengarelli I, Lodder EM, Kosmidis G, Bellin M, Zhang M et al (2017) Switch from fetal to adult SCN5A isoform in human induced pluripotent stem cell-derived cardiomyocytes unmasks the cellular phenotype of a conduction Disease-causing mutation. J Am Heart Assoc 6(7):e005135
van Weeghel M, Abdurrachim D, Nederlof R, Argmann CA, Houtkooper RH, Hagen J et al (2018) Increased cardiac fatty acid oxidation in a mouse model with decreased malonyl-CoA sensitivity of CPT1B. Cardiovasc Res 114(10):1324–1334
**a Y, Buja LM, Scarpulla RC, McMillin JB (1997) Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation. Proc Natl Acad Sci U S A 94(21):11399–11404
Yamanaka S, Zahanich I, Wersto RP, Boheler KR (2008) Enhanced proliferation of monolayer cultures of embryonic stem (ES) cell-derived cardiomyocytes following acute loss of retinoblastoma. PLoS One 3(12):e3896
Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M et al (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453(7194):524–528
Yang X, Pabon L, Murry CE (2014a) Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 114(3):511–523
Yang X, Rodriguez M, Pabon L, Fischer KA, Reinecke H, Regnier M et al (2014b) Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol 72:296–304
Yang X, Rodriguez ML, Leonard A, Sun L, Fischer KA, Wang Y et al (2019) Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Rep 13(4):657–668
Yazawa M, Hsueh B, Jia X, Pasca AM, Bernstein JA, Hallmayer J et al (2011) Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471(7337):230–234
Yokoo N, Baba S, Kaichi S, Niwa A, Mima T, Doi H et al (2009) The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Biophys Res Commun 387(3):482–488
You J-O, Rafat M, Ye GJC, Auguste DT (2011) Nanoengineering the heart: conductive scaffolds enhance connexin 43 expression. Nano Lett 11(9):3643–3648
Zhang J, Klos M, Wilson GF, Herman AM, Lian X, Raval KK et al (2012) Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res 111(9):1125–1136
Zhao Z, Lan H, El-Battrawy I, Li X, Buljubasic F, Sattler K et al (2018) Ion Channel expression and characterization in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cells Int 2018:6067096
Zhou P, Pu WT (2016) Recounting cardiac cellular composition. Circ Res 118(3):368–370
Zhu W, Zhao M, Mattapally S, Chen S, Zhang J (2018) CCND2 overexpression enhances the regenerative potency of human induced pluripotent stem cell-derived cardiomyocytes: Remuscularization of injured ventricle. Circ Res 122(1):88–96
Zhu W-Z, Santana LF, Laflamme MA (2009) Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS One 4(4):e5407
Zup**er C, Gibbons G, Dutta-Passecker P, Segiser A, Most H, Suter TM (2017) Characterization of cytoskeleton features and maturation status of cultured human iPSC-derived cardiomyocytes. Eur J Histochem 61(2):2763
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Der/die Autor(en), exklusiv lizenziert an Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chanthra, N., Uosaki, H. (2023). Reifung von aus pluripotenten Stammzellen gewonnenen Kardiomyozyten und Zukunftsperspektiven für die regenerative Medizin. In: Haider, K.H. (eds) Stammzellen. Springer, Cham. https://doi.org/10.1007/978-3-031-25378-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-031-25378-2_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-25377-5
Online ISBN: 978-3-031-25378-2
eBook Packages: Life Science and Basic Disciplines (German Language)